Our Strategic Partners
We represented the medical diagnostics division of Olympus (Clinical Chemistry Analyzers and Reagents) since May 1999. Beckman Coulter Inc later acquired the Diagnostic System Division of Olympus Corporation in August 2009 and Beckman Coulter Malaysia Sdn Bhd was formed due to this acquisition. Utas Maju Sdn Bhd will report to Beckman Coulter Malaysia Sdn Bhd a subsidiary of Beckman Coulter Inc., USA. The latest models introduce a slew of features such as spot photometry and probe crash detection. More than 100 instruments were installed nationwide. In the blood bank, Beckman Coulter is the proud manufacturer of a fully automated blood grouping analyzer for high throughput application.
An electrophoresis instrumentation manufacturing company that succeeded in satisfying a niche market in the local Hb & Protein analysis. The advance technology of electrophoresis instrument provides the user with reliable results. Every aspect of quality control is provided by this unit. Utas Maju represents Sebia since 2004.
We represent Hemasoft since 2003. We are proud to be the only company that has so far manages to install, integrate LIS and Blood Bank systems and interface them with a variety of analyzers from different suppliers. Being established in 1987, Hemasoft is an IT company specialized in Consulting, Development, R&D, Implementation and Technical Support of Data Management System for Health Care Sector.
T-Coag previously known as Trinity Biotech PLC before acquisition by Stago Group and renamed as T-Coag. We represent Trinity Biotech PLC since 2001. Designed to accommodate a variety of applications across a broad range of coagulation testing, the Tcoag is suitable for any laboratory demanding high throughput in a cost-sensitive environment.
We represent Techno Medica (Japan), since 2010, starts delivering Blood Gas Analyzer GASTAT-600, GASTAT-601, GASTAT-602i. Techno Medica then expanded their business in clinical laboratory, especially by having large share in test tube preparation system. By providing automation from registration to pre-analytic phase and patient identification, it helps to reduce patient waiting time, lessen burden of medical personnel and increase the safety will result in innovations in medical and clinical laboratory systems.
With motto of “Believe in Innovation”, Alifax is one of the most important Italian company specialized in the development, production and distribution of clinical diagnostic instrumentation for laboratory automation. Alifax is strongly oriented towards scientific research and technological innovation supported by constant investment program. We represent Alifax since 2010.
AccuVein’s vein viewing system is the world’s first handheld, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its patent portfolio which includes dozens of patents covering a broad range of imaging and medical diagnostic technologies. AccuVein is a global leader in medical imaging solutions. Vein illumination with our breakthrough device, allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving venipuncture, the most performed invasive medical procedure, and other vascular access procedures. The newest model we distribute now is AV500.
Philosys launched its company in May 2003 as technical consulting group specialized in research and development. The company provided technical consulting services locally as well as services abroad to foreign companies. Philosys was also involved in developing devices that can measure cholesterol, neutral fat and blood glucose simultaneously and provided its services as an OEM. By attaining necessary patents and technology, the company launched its brand “Gmate” in 2010. Philosys has successfully provided its products over 100 countries all over the globe and has adapted to the newest technological environment. Development of smartphone compatible blood glucose analyzers and applications has allowed Philosys to advance to a company leading in mobile healthcare.